Between BRCA1 and BRCA2, a key difference lies in the cancer predisposition rate, with BRCA1 mutants carry a higher lifetime risk (70%–80%) of developing breast cancer than BRCA2 (50%–60%; Roy et al., 2012). This evidence concerns the gene BRCA1 and cancer.